Why clinic ad compliance matters in Malaysia
Aesthetic and dental advertising in Malaysia sits under real regulation — principally the KKM/MOH Aesthetic Medical Practice Guidelines, the Medicines (Advertisement & Sale) Act 1956, and Malaysian Dental Council guidance for dental practices. These frameworks restrict things most clinics don't realise are a problem: before/after photography, guaranteed-outcome language, price-based inducements, testimonials about clinical results, and naming prescription products to the public. A non-compliant ad isn't just a takedown risk on Meta or Google — it can put the practice's standing at risk.
This self-check walks through the attributes that most often trigger a problem and, for each one you tick, explains which area of the rules it touches and how to say the same thing compliantly. It's the same logic we apply when we build campaigns for clinics — compliance and performance are one job, not two. Use it as a first pass, then confirm anything borderline with the relevant authority or your adviser. If you'd rather hand the whole thing over, our aesthetic clinic marketing programme builds compliant creative systems from the ground up, and the KKM & MDC advertising rules guide goes deeper on the specifics. Running a dental practice instead? Use the MDC version, scoped to Malaysian Dental Council guidance and dental-specific issues like specialist-title claims.
What this checklist checks
Server-rendered so the categories below are readable without ticking anything — the checker itself just tells you which of these apply to your specific ad.
- Guarantee/outcome language — restricted under KKM/MOH Aesthetic Medical Practice Guidelines and the Medicines (Advertisement & Sale) Act 1956.
- Before/after treatment photography — restricted under KKM/MOH Aesthetic Medical Practice Guidelines.
- Price-based inducements and promos — restricted under general Malaysian advertising standards for medical/aesthetic services.
- Naming prescription products or scheduled substances — restricted under the Medicines (Advertisement & Sale) Act 1956.
- Safety-minimising claims ("no risk," "painless") — restricted under KKM/MOH guidelines.
- Cure/treat claims for medical conditions — restricted under KKM/MOH guidelines and the Act 1956.
- Patient testimonials about clinical outcomes — restricted under KKM/MOH guidelines.
- Superlative/comparative claims ("best," "#1") — discouraged under general medical advertising standards.
- Manufactured urgency (contests, "limited slots") — restricted as an inducement to medical bookings.
Methodology — where this checklist comes from
Each item on this checklist is drawn from the same compliance framework we apply when reviewing creative for managed clinic accounts through our performance marketing service — the KKM/MOH Aesthetic Medical Practice Guidelines, the Medicines (Advertisement & Sale) Act 1956, and general Malaysian advertising standards for medical services. It is not a substitute for legal advice: treat a "no flags" result as a reasonable first pass, not clearance, and confirm anything borderline with the relevant authority or your own adviser before publishing.
Last reviewed: July 2026